Improvement in Schirmer test score observed with Tyrvaya treatment
July 12, 2022
1 minute watch
WASHINGTON – In this Healio video perspective from the American Society of Cataract and Refractive Surgery meeting, James A. Katz, M.D, deals with dry eye research that focuses on a patient’s overall well-being rather than just one eye.
Katz said that for a patient to feel better overall, both eyes need to be treated. In a study of nearly 900 participants, Tyrvaya (Varenicline Solution, Oyster Point Pharma) showed significant improvement in mean Schirmer test score as well as clinically significant improvement in the other eye.